Paper Details
- Home
- Paper Details
Fesoterodine: Pharmacological properties and clinical implications.
Author: CornuJean-Nicolas, GaméXavier, PeyronnetBenoit
Original Abstract of the Article :
Fesoterodine (as one of three drugs: dutasteride, finasteride and fesoterodine) was classified B (beneficial) by LUTS-FORTA 2014, indicating that it is a medicinal product with proven or obvious efficacy in the elderly, with limited side effects and/or safety concerns. A systematic literature review...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.ejphar.2018.05.036
データ提供:米国国立医学図書館(NLM)
Fesoterodine: A Promising Solution for Overactive Bladder
Overactive bladder (OAB) is a common condition that can significantly impact quality of life. This review explores the pharmacological properties and clinical implications of fesoterodine, a medication used to treat OAB. The study delves into the specific properties of fesoterodine that contribute to its effectiveness and tolerability.
Fesoterodine's Unique Properties: Balancing Efficacy and Tolerability
The study highlights four key properties of fesoterodine that explain its clinical benefits: its high affinity for both M2 and M3 muscarinic receptors, its poor penetration of the blood-brain barrier, its lack of hepatic first-pass activation, and its extended-release formulation. These properties contribute to fesoterodine's good balance between efficacy and tolerability, making it a valuable option for treating OAB.
Fesoterodine: A Leading First-Line Treatment for Overactive Bladder
This review underscores the significant role of fesoterodine in managing OAB. Its unique pharmacological profile, combined with its proven efficacy and tolerability, has established it as one of the leading first-line treatments for this condition.
Dr. Camel's Conclusion
Fesoterodine seems like a refreshing oasis in the desert of OAB! Its unique combination of properties makes it a compelling option for managing this condition. This review reminds us that the quest for better treatments is an ongoing journey, and we're lucky to have new tools like fesoterodine to help us navigate the challenges of OAB.
Date :
- Date Completed 2018-10-29
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.